Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.
von Samson-Himmelstjerna
G
G
Institute of Parasitology, Hannover School of Veterinary Medicine, Bünteweg 17, D-30559 Hannover, Germany.
Epe
C
C
Schimmel
A
A
Heine
J
J
D000287:Administration, Topical; D000722:Ancylostoma / Q000187:drug effects / Q000254:growth & development; D000723:Ancylostomatoidea / Q000187:drug effects / Q000235:genetics; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy* / Q000469:parasitology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology; D004285:Dogs; D004359:Drug Therapy, Combination; D005260:Female; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D007306:Insecticides / Q000008:administration & dosage / Q000627:therapeutic use*; D007814:Larva / Q000187:drug effects; D018942:Macrolides / Q000008:administration & dosage / Q000627:therapeutic use; D009349:Nematode Infections / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D000073943:Neonicotinoids; D009574:Nitro Compounds; D014119:Toxocara / Q000187:drug effects / Q000254:growth & development; D016896:Treatment Outcome
D000871:Anthelmintics; D007093:Imidazoles; D007306:Insecticides; D018942:Macrolides; D000073943:Neonicotinoids; D009574:Nitro Compounds; C082359:imidacloprid; C027837:moxidectin